Why did Ablynx board chairman Peter Fellner resign in wake of Novo's buyout offer?; Amgen vet Richard Paulson tapped to run Ipsen North America
→ What’s happening at Ablynx? On the same day Danish biopharma Novo Nordisk $NVO went public with its latest, $3.1 billion offer to buy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
